Advertisement

Loading...

4Front Ventures Corp.

FFNT.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.005
$0.00(0.00%)
Canadian Market opens in 16h 33m

4Front Ventures Corp. Fundamental Analysis

4Front Ventures Corp. (FFNT.CN) shows weak financial fundamentals with a PE ratio of -0.03, profit margin of -94.06%, and ROE of 7.89%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position104.60%
PEG Ratio-0.00

Areas of Concern

ROE7.89%
Operating Margin-21.40%
Current Ratio0.33
We analyze FFNT.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -0.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-0.4/100

We analyze FFNT.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

FFNT.CN struggles to generate sufficient returns from assets.

ROA > 10%
-34.72%

Valuation Score

Excellent

FFNT.CN trades at attractive valuation levels.

PE < 25
-0.03
PEG Ratio < 2
-0.00

Growth Score

Weak

FFNT.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

FFNT.CN shows balanced financial health with some risks.

Debt/Equity < 1
-4.07
Current Ratio > 1
0.33

Profitability Score

Weak

FFNT.CN struggles to sustain strong margins.

ROE > 15%
7.89%
Net Margin ≥ 15%
-94.06%
Positive Free Cash Flow
No

Key Financial Metrics

Is FFNT.CN Expensive or Cheap?

P/E Ratio

FFNT.CN trades at -0.03 times earnings. This suggests potential undervaluation.

-0.03

PEG Ratio

When adjusting for growth, FFNT.CN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values 4Front Ventures Corp. at -0.05 times its book value. This may indicate undervaluation.

-0.05

EV/EBITDA

Enterprise value stands at 11.13 times EBITDA. This signals the market has high growth expectations.

11.13

How Well Does FFNT.CN Make Money?

Net Profit Margin

For every $100 in sales, 4Front Ventures Corp. keeps $-94.06 as profit after all expenses.

-94.06%

Operating Margin

Core operations generate -21.40 in profit for every $100 in revenue, before interest and taxes.

-21.40%

ROE

Management delivers $7.89 in profit for every $100 of shareholder equity.

7.89%

ROA

4Front Ventures Corp. generates $-34.72 in profit for every $100 in assets, demonstrating efficient asset deployment.

-34.72%

Following the Money - Real Cash Generation

Operating Cash Flow

4Front Ventures Corp. generates limited operating cash flow of $-2.59M, signaling weaker underlying cash strength.

$-2.59M

Free Cash Flow

4Front Ventures Corp. generates weak or negative free cash flow of $-7.32M, restricting financial flexibility.

$-7.32M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

FFNT.CN converts -1.58% of its market value into free cash.

-1.58%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.03

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.05

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.03

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-4.07

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.33

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

7.89

vs 25 benchmark

ROA

Return on assets percentage

-0.35

vs 25 benchmark

ROCE

Return on capital employed

-0.13

vs 25 benchmark

How FFNT.CN Stacks Against Its Sector Peers

MetricFFNT.CN ValueSector AveragePerformance
P/E Ratio-0.0327.91 Better (Cheaper)
ROE788.56%687.00% Neutral
Net Margin-94.06%-45285.00% (disorted) Weak
Debt/Equity-4.070.33 Strong (Low Leverage)
Current Ratio0.332795.76 Weak Liquidity
ROA-34.72%-13557.00% (disorted) Weak

FFNT.CN outperforms its industry in 2 out of 6 key metrics, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 4Front Ventures Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ